BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib

August 25, 2021– Palo Alto, California & Shanghai & Princeton, New Jersey (Business Wire) — LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major Asian markets, and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced the first patient has been treated in a Phase 2a clinical trial of infigratinib in patients with locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with fibroblast growth factor receptor-2 (FGFR2) gene amplification and other advanced solid tumors with FGFR genomic alterations.

“We believe that infigratinib could have a meaningful impact for people living with gastric cancer as well as many other cancers with FGFR alterations, and are pleased LianBio is initiating this clinical trial in China where more therapeutic options are needed to match the growing diagnosis rate.”

“Infigratinib is a potent and selective FGFR inhibitor that has demonstrated compelling clinical activity across multiple tumor types with FGFR alterations,” said Yizhe Wang, Ph.D., chief executive officer of LianBio. “Given the disproportionately high prevalence rate of gastric cancer in China, LianBio is pursuing a region-specific development strategy focused on this area of great unmet need. This study marks LianBio’s first trial initiation and demonstrates our continued progress in delivering potentially transformational medicines to patients in Asia.” Continue reading

6 Things Every American Needs And Deserves!

While, we have always, witnessed, partisan – politics, in some forms, in this nation, it seems, in recent memory, never, to the degree, we see it, today! When, this behavior, transforms itself, into, being, obstructionists, and, little, of consequence, seems to get achieved, and/ or, even, addressed, doesn’t that seem, to be, concerning, the quality future, the generations – to – follow, need and deserve? When nearly, every American, needs and deserves, certain things, and, politics, interferes, we must address this, sooner, rather than later! With, that in mind, this article will attempt to, briefly, consider, examine, review, and discuss, 6 specific things/ areas, which must be addressed, in a well – considered, timely manner.

1. Access to affordable medicine: Although,we like to pride – ourselves, on our health – care, system, the data, says something, different! In, nearly, every area/ analysis, we are, at – best, middle – of – the – road, in how we treat, the health of our people! Why are we, the only, major nation, where access to quality care, depends on one’s personal finances, etc? Why is the cost of prescription drugs, so much higher, than the rest – of – the – world? Why is medical/ health insurance, so costly, and limiting? Shouldn’t quality health care be a right, rather than, simply, a privilege, to the few? Continue reading

Viatris Inc. Launches as a New Kind of Healthcare Company, Positioned to Meet the World’s Evolving Healthcare Needs

Combination of Mylan and Pfizer’s Upjohn Business Focused on Access and Improved Patient Health

PITTSBURGH, Nov. 16, 2020 — Viatris Inc. (NASDAQ: VTRS) launched today following the successful combination of Mylan N.V. and Pfizer’s Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing and distribution expertise with proven regulatory, medical and global commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.

Viatris is a new kind of global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life by expanding access to medicines regardless of geography or circumstance; advancing responsible, sustainable operations and targeted innovation to improve patient health; and leveraging its collective expertise to connect more people to more products and services.

Viatris Executive Chairman Robert J. Coury said: “Today, we celebrate the launch of Viatris, the culmination of more than a decade of strategic, thoughtful work to build a global company with the breadth and depth to provide more efficient access to high-quality medicines to patients and healthcare systems around the world. I am extremely confident about the opportunities ahead for Viatris and the value we expect our company will create for all stakeholders – from our patients and employees, to customers and shareholders.” Continue reading